Your Article Summary
Merck and Co., Inc. Provides Update on Previously-Disclosed U.S. Department of Justice Investigation Relating to VIOXX
Merck & Co., 03/24/09
Merck and Co., Inc. reported that it has received a letter from the U.S. Attorney's Office for the District of Massachusetts advising the company that it is a target of a previously-disclosed federal grand jury investigation. The investigation relates to activities in connection with VIOXX, a medicine that Merck voluntarily withdrew from the market in 2004. The company has previously disclosed the government's investigation, which has been ongoing since 2004, in various filings with the U. S. Securities and Exchange Commission.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Hospira Buys Infection Control Vendor
HealthDataManagement, 12/11/09
Mediware Makes Two Buys
HealthDataManagement, 12/10/09
Visanne cleared for market launch in Europe as new treatment option for endometriosis
BayNews International, 12/08/09
Article Search
Sponsor


See Latest Articles


